Essential fatty acid supplementation in tardive dyskinesia

Author(s): Jordan, B., Peslow, E., Rubinstein, M., Rotrosen, J.

Journal/Book: American Journal of Psychiatry. 1986; 143: 912-914.

Abstract: Preclinical and clinical observations suggest that enhancement o f prostaglandin activity inhibits catecholamine release and may have antidyskinetic effects. A double-blind therapeutic trial with prostaglandin precursor essential fatty acids was conducted in 16 patients with tardive dyskinesia. No beneficial effects were seen.

Keyword(s): Evening primrose oil

Zurück | Weiter